605 related articles for article (PubMed ID: 15739824)
1. Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: 2. Factors that may have influenced the marked changes in sales volumes during the 1990s.
Mårdh PA; Wågström J; Landgren M; Holmén J
Infect Dis Obstet Gynecol; 2004 Jun; 12(2):99-108. PubMed ID: 15739824
[TBL] [Abstract][Full Text] [Related]
2. Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: I. Analyses of a unique database.
Mårdh PA; Wågström J; Landgren M; Holmén J
Infect Dis Obstet Gynecol; 2004 Jun; 12(2):91-7. PubMed ID: 15739823
[TBL] [Abstract][Full Text] [Related]
3. Women's use of over-the-counter antifungal medications for gynecologic symptoms.
Ferris DG; Dekle C; Litaker MS
J Fam Pract; 1996 Jun; 42(6):595-600. PubMed ID: 8656170
[TBL] [Abstract][Full Text] [Related]
4. [Genital candidiasis].
Ono F; Yasumoto S
Nihon Rinsho; 2009 Jan; 67(1):157-61. PubMed ID: 19177766
[TBL] [Abstract][Full Text] [Related]
5. Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes.
Yano J; Sobel JD; Nyirjesy P; Sobel R; Williams VL; Yu Q; Noverr MC; Fidel PL
BMC Womens Health; 2019 Mar; 19(1):48. PubMed ID: 30925872
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and patient awareness of selected potential drug interactions with self-medication.
Indermitte J; Reber D; Beutler M; Bruppacher R; Hersberger KE
J Clin Pharm Ther; 2007 Apr; 32(2):149-59. PubMed ID: 17381665
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of vaginal colonization by drug-resistant Candida species in college-age women with previous exposure to over-the-counter azole antifungals.
Mathema B; Cross E; Dun E; Park S; Bedell J; Slade B; Williams M; Riley L; Chaturvedi V; Perlin DS
Clin Infect Dis; 2001 Sep; 33(5):E23-7. PubMed ID: 11477529
[TBL] [Abstract][Full Text] [Related]
8. Trends in prescribing for vulvovaginal candidiasis in the United States.
McCaig LF; McNeil MM
Pharmacoepidemiol Drug Saf; 2005 Feb; 14(2):113-20. PubMed ID: 15386715
[TBL] [Abstract][Full Text] [Related]
9. Prolonged (3-month) mycological cure rate after boric acid suppositories in diabetic women with vulvovaginal candidiasis.
Ray D; Goswami R; Dadhwal V; Goswami D; Banerjee U; Kochupillai N
J Infect; 2007 Oct; 55(4):374-7. PubMed ID: 17692922
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis.
Seidman LS; Skokos CK
Infect Dis Obstet Gynecol; 2005 Dec; 13(4):197-206. PubMed ID: 16338779
[TBL] [Abstract][Full Text] [Related]
11. Facts and myths on recurrent vulvovaginal candidosis--a review on epidemiology, clinical manifestations, diagnosis, pathogenesis and therapy.
Mårdh PA; Rodrigues AG; Genç M; Novikova N; Martinez-de-Oliveira J; Guaschino S
Int J STD AIDS; 2002 Aug; 13(8):522-39. PubMed ID: 12194734
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical care in community pharmacies: practice and research in Sweden.
Westerlund LT; Björk HT
Ann Pharmacother; 2006 Jun; 40(6):1162-9. PubMed ID: 16735653
[TBL] [Abstract][Full Text] [Related]
13. Monthly itraconazole versus classic homeopathy for the treatment of recurrent vulvovaginal candidiasis: a randomised trial.
Witt A; Kaufmann U; Bitschnau M; Tempfer C; Ozbal A; Haytouglu E; Gregor H; Kiss H
BJOG; 2009 Oct; 116(11):1499-505. PubMed ID: 19583713
[TBL] [Abstract][Full Text] [Related]
14. Vulvovaginal candidiasis in a Flemish patient population.
De Vos MM; Cuenca-Estrella M; Boekhout T; Theelen B; Matthijs N; Bauters T; Nailis H; Dhont MA; Rodriguez-Tudela JL; Nelis HJ
Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555
[TBL] [Abstract][Full Text] [Related]
15. Exploring unexplained twofold differences in sales of cardiovascular drugs between two neighbouring Swedish municipalities.
Jonsson L; Lundborg CS
Pharmacoepidemiol Drug Saf; 2005 May; 14(5):349-55. PubMed ID: 15700323
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological survey of vulvovaginal candidosis in Sfax, Tunisia.
Amouri I; Sellami H; Borji N; Abbes S; Sellami A; Cheikhrouhou F; Maazoun L; Khaled S; Khrouf S; Boujelben Y; Ayadi A
Mycoses; 2011 Sep; 54(5):e499-505. PubMed ID: 21039942
[TBL] [Abstract][Full Text] [Related]
17. Survey of incidence, lifetime prevalence, and treatment of self-reported vulvovaginal candidiasis, United States, 2020.
Benedict K; Singleton AL; Jackson BR; Molinari NAM
BMC Womens Health; 2022 May; 22(1):147. PubMed ID: 35538480
[TBL] [Abstract][Full Text] [Related]
18. Improving appropriate use of antifungal medications: the role of an over-the-counter vaginal pH self-test device.
Roy S; Caillouette JC; Faden JS; Roy T; Ramos DE
Infect Dis Obstet Gynecol; 2003; 11(4):209-16. PubMed ID: 15108867
[TBL] [Abstract][Full Text] [Related]
19. Recurrent vulvovaginal candidiasis.
Blostein F; Levin-Sparenberg E; Wagner J; Foxman B
Ann Epidemiol; 2017 Sep; 27(9):575-582.e3. PubMed ID: 28927765
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
